The 4WHIM Trial

For People Living with WHIM Syndrome

No longer enrolling

About the 4WHIM Trial

The 4WHIM clinical research study is no longer enrolling. Results of this phase 3 study will determine if the investigational study drug, mavorixafor, helps people with WHIM syndrome by targeting the way the disease works and safely reduces bacterial infections and warts.

Clinical Research

Considering a clinical trial? Learn more about clinical research studies so you can make an informed decision.


Learn more about no-cost genetic testing, clinical trials and WHIM syndrome.

Stay informed and follow the 4WHIM Trial

Enter your email address to receive updates about the 4WHIM Trial, WHIM syndrome, and X4 Pharmaceuticals news.